Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
All content curated by
Published in Eye Care

Journal Scan / Research · April 13, 2024

Association Between SGLT2 Inhibitor Therapy and Diabetic Retinopathy Progression

Graefe's Archive for Clinical and Experimental Ophthalmology

 

Additional Info

Graefe's Archive for Clinical and Experimental Ophthalmology
SGLT2 inhibitors and diabetic retinopathy progression
Graefes Arch. Clin. Exp. Ophthalmol 2024 Mar 01;262(3)753-758, JB Nadelmann, CG Miller, B McGeehan, Y Yu, BL VanderBeek

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading